| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cue Biopharma, Inc. | SVP, GENERAL COUNSEL | Stock Option (right to buy) | 70,000 | 03 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CUE | Cue Biopharma, Inc. | 26 Sep 2025 | 2 | $0 | 4 | SVP, GENERAL COUNSEL | 05 Dec 2025, 18:54 |
| CUE | Cue Biopharma, Inc. | 21 Mar 2025 | 1 | $0 | 4 | SVP, GENERAL COUNSEL | 25 Mar 2025, 16:00 |
| CUE | Cue Biopharma, Inc. | 05 Jun 2024 | 1 | $0 | 4 | SVP, GENERAL COUNSEL | 07 Jun 2024, 16:00 |
| CUE | Cue Biopharma, Inc. | 06 Mar 2024 | 1 | $0 | 4 | SVP, GENERAL COUNSEL | 08 Mar 2024, 16:00 |
| CUE | Cue Biopharma, Inc. | 21 Jul 2023 | 1 | $0 | 4 | SVP, GENERAL COUNSEL | 25 Jul 2023, 12:27 |
| CUE | Cue Biopharma, Inc. | 16 Feb 2023 | 1 | $0 | 4 | SVP, GENERAL COUNSEL | 21 Feb 2023, 16:00 |
| CUE | Cue Biopharma, Inc. | 09 Feb 2022 | 2 | $0 | 4 | SVP, GENERAL COUNSEL | 29 Mar 2022, 16:13 |